Morgan L Prust1, Aparna Nutakki1, Gloria Habanyama1, Lorraine Chishimba1, Mashina Chomba1, Moses Mataa1, Kunda Yumbe1, Stanley Zimba1, Rebecca F Gottesman1, Mona N Bahouth1, Deanna R Saylor1. 1. Department of Neurology (MLP), Division of Neurocritical Care, Columbia University Medical Center, New York, NY; Rush University Medical College (AN), Chicago, IL; Department of Medicine (GH, LC, MC, MM, DRS), University of Zambia School of Medicine, Lusaka; Department of Medicine (KY, SZ, DRS), University Teaching Hospital, University of Zambia, Lusaka; and Department of Neurology (RFG, MNB, DRS), Johns Hopkins University School of Medicine, Baltimore, MD.
Abstract
BACKGROUND AND OBJECTIVES: Preventing complications of stroke such as poststroke aspiration pneumonia (PSAP) may improve stroke outcomes in resource-limited settings. We investigated the incidence and associated mortality of PSAP in Zambia. METHODS: We conducted a prospective cohort study of adults with stroke at University Teaching Hospital (Lusaka, Zambia) between December 2019 and March 2020. NIH Stroke Scale, Glasgow Coma Scale, and Modified Rankin Scale scores and 9 indicators of possible PSAP were collected serially over each participant's admission. PSAP was defined as ≥4 indicators present, and possible PSAP as 2%-3% present. T tests and χ2 tests were used to compare clinical parameters across PSAP groups. Logistic regression was used to assess the relative effects of age, sex, PSAP status, and initial stroke severity on inpatient mortality. RESULTS: We enrolled 125 participants. Mean age was 60 ± 16 years, 61% were female, 55% of strokes were ischemic, and the baseline NIH Stroke Scale score was 19.7 ± 8.7. Thirty-eight (30%) had PSAP, and 32 (26%) had possible PSAP. PSAP was associated with older age and more adverse stroke severity scores. Fifty-nine percent of participants with PSAP died compared with 39% with possible PSAP and 8% with no PSAP. PSAP status independently predicted inpatient mortality after controlling for age, sex, and initial stroke severity. Swallow screening was not performed for any participant. DISCUSSION: PSAP is common and life threatening in Zambia, especially among older participants with severe stroke presentations. PSAP was associated with significantly increased mortality independent of initial stroke severity, suggesting that interventions to mitigate PSAP may improve stroke outcomes in Zambia and other resource-limited settings.
BACKGROUND AND OBJECTIVES: Preventing complications of stroke such as poststroke aspiration pneumonia (PSAP) may improve stroke outcomes in resource-limited settings. We investigated the incidence and associated mortality of PSAP in Zambia. METHODS: We conducted a prospective cohort study of adults with stroke at University Teaching Hospital (Lusaka, Zambia) between December 2019 and March 2020. NIH Stroke Scale, Glasgow Coma Scale, and Modified Rankin Scale scores and 9 indicators of possible PSAP were collected serially over each participant's admission. PSAP was defined as ≥4 indicators present, and possible PSAP as 2%-3% present. T tests and χ2 tests were used to compare clinical parameters across PSAP groups. Logistic regression was used to assess the relative effects of age, sex, PSAP status, and initial stroke severity on inpatient mortality. RESULTS: We enrolled 125 participants. Mean age was 60 ± 16 years, 61% were female, 55% of strokes were ischemic, and the baseline NIH Stroke Scale score was 19.7 ± 8.7. Thirty-eight (30%) had PSAP, and 32 (26%) had possible PSAP. PSAP was associated with older age and more adverse stroke severity scores. Fifty-nine percent of participants with PSAP died compared with 39% with possible PSAP and 8% with no PSAP. PSAP status independently predicted inpatient mortality after controlling for age, sex, and initial stroke severity. Swallow screening was not performed for any participant. DISCUSSION: PSAP is common and life threatening in Zambia, especially among older participants with severe stroke presentations. PSAP was associated with significantly increased mortality independent of initial stroke severity, suggesting that interventions to mitigate PSAP may improve stroke outcomes in Zambia and other resource-limited settings.
Authors: Craig S Anderson; Hisatomi Arima; Pablo Lavados; Laurent Billot; Maree L Hackett; Verónica V Olavarría; Paula Muñoz Venturelli; Alejandro Brunser; Bin Peng; Liying Cui; Lily Song; Kris Rogers; Sandy Middleton; Joyce Y Lim; Denise Forshaw; C Elizabeth Lightbody; Mark Woodward; Octavio Pontes-Neto; H Asita De Silva; Ruey-Tay Lin; Tsong-Hai Lee; Jeyaraj D Pandian; Gillian E Mead; Thompson Robinson; Caroline Watkins Journal: N Engl J Med Date: 2017-06-22 Impact factor: 91.245
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Kigocha Okeng'o; Pilly Chillo; William K Gray; Richard W Walker; William Matuja Journal: J Stroke Cerebrovasc Dis Date: 2016-11-29 Impact factor: 2.136
Authors: Marcel Arnold; Kai Liesirova; Anne Broeg-Morvay; Julia Meisterernst; Markus Schlager; Marie-Luise Mono; Marwan El-Koussy; Georg Kägi; Simon Jung; Hakan Sarikaya Journal: PLoS One Date: 2016-02-10 Impact factor: 3.240
Authors: Willeke F Westendorp; Jan-Dirk Vermeij; Nina A Hilkens; Matthijs C Brouwer; Ale Algra; H Bart van der Worp; Diederik Wj Dippel; Diederik van de Beek; Pual J Nederkoorn Journal: Eur Stroke J Date: 2018-03-08
Authors: Morgan L Prust; Amir Mbonde; Clio Rubinos; Gentle S Shrestha; Morenikeji Komolafe; Deanna Saylor; Halinder S Mangat Journal: Neurocrit Care Date: 2022-07-16 Impact factor: 3.532
Authors: Aaron Berkowitz; Nirali Vora; Morgan L Prust; Deanna Saylor; Stanley Zimba; Fred Stephen Sarfo; Gentle S Shrestha Journal: Stroke Date: 2022-01-20 Impact factor: 7.914